Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis

This study has been withdrawn prior to enrollment.

(Sponsor withdrew study for business reasons)

Sponsor:

Information provided by (Responsible Party):

GlaxoSmithKline ( Human Genome Sciences Inc., a GSK Company )

ClinicalTrials.gov Identifier:

NCT01434576

First received: September 1, 2011

Last updated: October 29, 2012

Last verified: October 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)